Tibet Weixinkang Medicine Co., Ltd. (SHA:603676)
11.23
+0.03 (0.27%)
Feb 27, 2026, 3:00 PM CST
Tibet Weixinkang Medicine Market Cap
Tibet Weixinkang Medicine has a market cap or net worth of 4.86 billion as of February 27, 2026. Its market cap has increased by 16.10% in one year.
Market Cap
4.86B
Enterprise Value
3.85B
Revenue
1.17B
Ranking
n/a
PE Ratio
21.66
Stock Price
11.23
Market Cap Chart
Since July 21, 2017, Tibet Weixinkang Medicine's market cap has increased from 3.37B to 4.86B, an increase of 44.19%. That is a compound annual growth rate of 4.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 4.84B | 6.46% |
| Dec 31, 2025 | 4.55B | 5.04% |
| Dec 31, 2024 | 4.33B | -4.60% |
| Dec 29, 2023 | 4.54B | -34.48% |
| Dec 30, 2022 | 6.93B | 71.03% |
| Dec 31, 2021 | 4.05B | 6.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jul 21, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tibet Duo Rui Pharmaceutical | 5.06B |
| Jianmin Pharmaceutical Group | 5.04B |
| Newland Pharmaceutical | 5.02B |
| Bide Pharmatech | 5.02B |
| Shanghai Jiaoda Onlly Co.,Ltd | 4.91B |
| Guizhou Sanli Pharmaceutical Co.,Ltd | 4.89B |
| Shanghai Xiao Fang Pharmaceutical | 4.79B |
| Ningbo Menovo Pharmaceutical | 4.72B |